Neoleukin Therapeutics Inc
Change company Symbol lookup
Select an option...
NLTX Neoleukin Therapeutics Inc
CTO CTO Realty Growth Inc
WHR Whirlpool Corp
OTIS Otis Worldwide Corp
GME GameStop Corp
ECF Ellsworth Growth and Income Fund Ltd
SILK Silk Road Medical Inc
HLVX Hillevax Inc
AIZ Assurant Inc
NOTV Inotiv Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company's lead product candidate, NL-201, is an interleukin-2 (IL-2)/ interleukin-15 (IL-15) immunotherapy designed to eliminate binding to the alpha subunit of the IL-2 receptor (also known as CD25) while enhancing binding to the beta and gamma subunits. NL-201 is designed to mimic the therapeutic activity of the cytokines IL-2 and IL-15 for the treatment of various types of cancer, including renal cell carcinoma (RCC), melanoma and hematological malignancies. Its Neoleukin platform uses a set of advanced computational algorithms and methods to design functional de novo proteins. NL-201 holds promise in combination with cell therapy to expand and maintain populations of transplanted CAR-T and natural killer (NK) cells.

Closing Price
$0.59
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
40,499

10-day average volume:
60,091
40,499

Booking Holdings Inc. Stock Outperforms Market Despite Losses On The Day

4:40 pm ET October 19, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Booking Holdings Inc. (BKNG) sank 0.12% to $1,771.82 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.67% to 3,695.16 and Dow Jones Industrial Average falling 0.33% to 30,423.81. The stock's fall snapped a two-day winning streak. Booking Holdings Inc. closed $943.84 short of its 52-week high ($2,715.66), which the company achieved on February 16th.

Despite its losses, the stock outperformed some of its competitors Wednesday, as Trip.com Group Ltd. ADR (TCOM) fell 7.79% to $22.62, Expedia Group Inc. (EXPE) fell 2.03% to $96.12, and TripAdvisor Inc. (TRIP) fell 3.20% to $23.61.true Trading volume (313,517) remained 68,712 below its 50-day average volume of 382,229.

Data source: Dow Jones Market Data, FactSet. Data compiled October 19, 2022.

	

(END) Dow Jones Newswires

October 19, 2022 16:40 ET (20:40 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.